For InvestorsAntares Pharma: Making Medicines Feel Better

Recent News

Information contained in these press releases should be considered accurate only as of the date it was prepared. Information may change over time. Do not assume that the information remains accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

08 Sep 2021
Antares Pharma to Participate in the H.C. Wainright 23rd Annual Global Investment Conference

05 Aug 2021
Antares Pharma Reports Second Quarter 2021 Financial And Operating Results

28 Jul 2021
Antares Pharma to Report Second Quarter 2021 Financial and Operating Results

22 Jul 2021
Antares Pharma Announces FDA Acceptance of IND Application for ATRS 1902 For Adrenal Crisis Rescue

07 Jul 2021
Antares Pharma To Present At The Ladenburg Thalmann Annual Healthcare Conference

28 Jun 2021
Antares Pharma Announces Partner Idorsia Initiates The Phase 3 Study with Selatogrel For Acute Myocardial Infarction

22 Jun 2021
Antares Pharma Announces Submission of IND Application for ATRS 1902 For Adrenal Crisis Rescue

15 Jun 2021
Antares Pharma to Present at the Raymond James Human Health Innovations Conference

26 May 2021
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference

06 May 2021
Antares Pharma Reports First Quarter 2021 Financial and Operating Results

06 May 2021
Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial

03 May 2021
Antares Pharma Announces Poster Presentation At The Pediatric Endocrine Society 2021 Virtual Annual Meeting

28 Apr 2021
Antares Pharma To Participate In The 7th Annual Truist Securities 2021 Life Sciences Summit

27 Apr 2021
Antares Pharma to Report First Quarter 2021 Financial and Operating Results

26 Apr 2021
Antares Pharma Appoints Dr. Peter Richardson As Executive Vice President, Research And Development And Chief Medical Officer

02 Mar 2021
Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results

24 Feb 2021
Antares Pharma to Present At Two Upcoming Investor Conferences

23 Feb 2021
Antares Pharma to Report Fourth Quarter And Full-Year 2020 Financial and Operating Results

17 Feb 2021
Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference

11 Jan 2021
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million

For Investors

Press Release Archive



Sign up for breaking news on ATRS

* indicates required